|
|
View Clinical Trial (Medical Research Study)
|
Add-on Simvastatin in Schizophrenia Trial - NCT00605995-10032 (Clinical Trial 201244)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy201244.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
New York |
|
State:
|
|
NY |
| Zip Code: |
|
10032 |
| Conditions: |
|
Schizophrenia |
| Purpose: |
|
The overall purpose of this study is to determine whether the cholesterol-lowering drug
simvastatin is effective in the treatment of symptoms of schizophrenia. The primary
hypothesis is that patients with schizophrenia receiving add-on treatment with simvastatin
will improve clinically (as measured mainly by symptom severity) compared with patients
receiving placebo, and that this improvement will be accompanied by concomitant reduction in
peripheral inflammatory markers.
|
| Study summary: |
|
The identification of alternative therapies with the capacity to dampen inflammatory
processes and reduce serum cholesterol takes on additional significance given independent
concerns about heightened cardiovascular risk in schizophrenia patients, through exposure to
antipsychotic drugs, increased cholesterol levels, metabolic syndrome and obesity, and
smoking. |
| Criteria: |
|
Inclusion Criteria:
- Age 18-70 years
- Available for follow up during the study protocol
- DSM-IV schizophrenia
- Positive and Negative Syndrome Scale (PANSS) baseline score of ≥50
- Score of 3 or higher on the Severity of Illness scale of the Clinical Global
Impression (CGI)
- Not completely refractory to antipsychotics: evidence for at least partial
responsiveness to antipsychotic medication
- Evidence for current clinical stability
- Capacity to provide informed consent
- Provided informed consent
- Patients taking concomitant, non-investigational medications that are not listed in
Exclusion Criteria #1
- Patients speaking Spanish or English
- Women using acceptable methods of birth control, including barrier method
Exclusion Criteria:
- Currently taking a statin OR any of the following:
- Other lipid-lowering drug;
- Anti-inflammatory drugs or aspirin;
- Systemic antibiotic, anti-viral or anti-fungal drugs (within the past 4 weeks);
- Potent inhibitors of the cytochrome P450 isoform 3A4 (CYP3A4);
- Digoxin (Lanoxin®), nefazodone (Serzone®), niacin, cyclosporine (Neoral®,
Sandimmune®), danazol, warfarin (Coumadin®), amiodarone, verapamil, Cordarone®,
or Inderal®.
- Patients with known hypersensitivity to simvastatin or any other statin drug
- Active liver disease or unexplained persistent elevations of serum transaminases
- Renal insufficiency
- Serious or unstable medical condition that require close medical attention, such as
cancer, unstable heart failure, uncontrolled hypertension/asthma/COPD
- Current drug use disorder (abuse/dependence)
- Pregnancy and lactation
- Psychiatric disorders other than schizophrenia or schizoaffective disorder requiring
pharmacotherapy
- Suicidal or homicidal intent
- Severe cognitive impairment that might compromise competency to sign informed consent
or the validity of the cognitive outcome measure
- Organic brain disorder, including epilepsy; mental retardation; or a medical
condition whose pathology or treatment would likely alter the presentation or
treatment of schizophrenia
- Current participation in another clinical trial
- Patients on more than 2 anti-psychotic medications (patients will not be tapered off
effective medications for the purpose of participating in research) |
|
|
|
| Study is available at: |
|
Columbia University Medical Center
New York, NY 10032
United States
Primary Contact:
Raz Gross, M.D., MPH
Email: rg547@columbia.edu
Phone: 212-304-6591 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|